Salute e Benessere

CEPI Expands Partnership with Valneva with a $41.3 Million Grant to Support…

Valneva to receive up to $41.3 million from CEPI and the European Union to expand access to chikungunya vaccine, IXCHIQ®Funding will support clinical trials in vulnerable groups, such as children and pregnant women Partnership will also support technology transfer to an additional manufacturer to supply IXCHIQ® to Asian LMICsIXCHIQ®isalreadyapproved for use in adults 18 years of age and older in the U.S., Canada and EuropeOslo, Norway, and Saint-Herblain, France, July...
Nasdaq GlobeNewswire
22/07/2024

Transparency Notifications from Shareholders

Transparency Notifications from ShareholdersPRESS RELEASE REGULATED INFORMATION 19 July 2024, 06:30 pm CESTGhent, Belgium – 19 July 2024 – Sequana Medical NV (Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces today that it received a transparency notification from the shareholder listed below, notifying the number of voting rights attached to the shares…
Nasdaq GlobeNewswire
19/07/2024

Information on the Total Number of Voting Rights (Denominator) following…

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment1 that will allow Oxurion to focus on developing innovative therapeutics to preserve the vision of elderly people, targeting potential market opportunities of USD 3-6 billion...
Nasdaq GlobeNewswire
19/07/2024

BioSenic S.A. : Transparency notification received from Mr François Rieger

PRESS RELEASE – REGULATED INFORMATION Article 14 of the Law of 2 May 2007 on disclosure of major holdings Mont-Saint-Guibert, Belgium, July 19, 2024, 6pm CEST –BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy, today announces that it has received a transparency notification from Mr François Rieger. The details of the transparency notification are set out below and the full text of...
Nasdaq GlobeNewswire
19/07/2024

Half-Year Review of Inventiva's Liquidity Contract with Kepler Cheuvreux

Daix (France), Long Island City (New York, United States), July 19, 2024– Inventiva (Euronext Paris and Nasdaq: IVA) (“ Inventiva ” or the “ Company ”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with metabolic dysfunction-associated steatohepatitis (“ MASH ”), also known as non-alcoholic steatohepatitis (“ NASH ”), and other diseases with significant unmet medical needs, today announced the half-year...
Nasdaq GlobeNewswire
19/07/2024

Cell Therapy Market to Attain a USD 190.91 Billion Valuation in 2031, Rising…

Download a detailed overview: Download a detailed overview: https://www.skyquestt.com/sample-request/cell-therapy-market Cell Therapy Market Overview: Segments covered in Cell Therapy Market are as follows: Request Free Customization of this report: https://www.skyquestt.com/speak-with-analyst/cell-therapy-market High Demand for Novel Cancer Treatments to Help Oncology Segment Maintain Prominence Cases of cancer are increasing rapidly on a global level and...
PR Newswire
19/07/2024

Cancer Gene Therapy Market to Attain a USD 12.63 Billion by 2031; Advancements…

Download a detailed overview: Download a detailed overview: https://www.skyquestt.com/sample-request/cancer-gene-therapy-market Cancer Gene Therapy Market Overview: Segments covered in Cancer Gene Therapy Market are as follows: Request Free Customization of this report: https://www.skyquestt.com/speak-with-analyst/cancer-gene-therapy-market Gene Therapies for Breast Cancer Treatment are Slated to be Highly Popular Going Forward The incidence of breast...
PR Newswire
19/07/2024

Immunotherapy Drugs Market worth $580.6 billion by 2029 driven by Technological…

Browse in-depth TOC on "Immunotherapy Drugs Market" Browse in-depth TOC on "Immunotherapy Drugs Market" 341 - Tables 53 - Figures 348 - Pages MERCK & CO., INC. (US): Innovator in Immunotherapy Merck & Co., Inc. stands out as a leader in the immunotherapy sector, showcasing a robust pipeline of advanced immunotherapeutic drugs through the utilization of cutting-edge biotechnologies. The company's expertise spans therapeutic areas including oncology, immunology,...
PR Newswire
19/07/2024

Indwelling Catheters Market to reach US$ 1.9 Billion by 2031: Rising Awareness…

Indwelling catheters offer a less invasive alternative to traditional methods for managing urinary issues, driving their adoption. Growth in healthcare expenditure, particularly in developing regions, supports the adoption of advanced medical devices like indwelling catheters. Indwelling catheters offer a less invasive alternative to traditional methods for managing urinary issues, driving their adoption. Growth in healthcare expenditure, particularly in developing regions, supports the...
PR Newswire
19/07/2024

New Paper Underscores Inflammation's Role in Atherosclerosis

The paper has four main sections: The paper has four main sections: Assessment & Treatment of Inflammation in Atherosclerosis is authored by four international experts: READ WHITE PAPER: Assessment & Treatment of Inflammation in Atherosclerosis STATEMENT FROMPETER LIBBY, MD, PRESIDENT, INTERNATIONAL ATHEROSCLEROSIS SOCIETY AND CHAIR OF THE WHITE PAPER EXPERT PANEL:"Atherosclerosis is a primary cause of cardiovascular disease, the leading cause of death worldwide...
PR Newswire
19/07/2024

I Love Fruit & Veg from Europe: the beneficial properties of berries

Berries are an obvious choice because they contain plenty of water and fibre, vitamins, mineral salts and antioxidants. They also contain polyphenols, which have a fat-burning effect. Whether eaten fresh, in preserves or juices, they make a perfect snack for those on a diet: berries are low in calories but highly nutritious and they can give a sense of fullness; they can also help to control cholesterol. Furthermore, they are easily absorbed and have diuretic, purifying and laxative properties -…
PR Newswire
19/07/2024

Inspire Medical Systems, Inc. Announces CE Mark Certification under the European…

/745) for Inspire therapy. “Inspire has a long history of compliance to the European Union's (EU) quality system and CE mark requirements, with uninterrupted CE mark approval since 2010,” said Tim Herbert, Chairman and President of Inspire. “The Inspire team has worked diligently with our notified body in Europe to complete the review process, which included obtaining temporary approval through derogation authorization to continue to deliver Inspire product in several countries.”“In 2017...
Nasdaq GlobeNewswire
19/07/2024

Inspire Medical Systems, Inc. Announces CE Mark Certification of Full-Body MRI…

“Expanding compatible use to include full-body MRI is a significant milestone in our effort to bring Inspire to more obstructive sleep apnea patients who struggle with CPAP. Providing the full range of scan options enables us to better help all current and future patients with their imaging needs,” said Tim Herbert, Chairman and CEO of Inspire. “This full-body MRI compatibility has been an important benefit for patients in the United States for the past two years, and this new approval will...
Nasdaq GlobeNewswire
19/07/2024

Nicox announces attendance at upcoming conferences

Press ReleaseNicox announces attendance at upcoming conferences July 19 th, 2024 – release at 7:30 am CETSophia Antipolis, France Nicox SA(Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, today announced its attendance at several upcoming international conferences: H.C. Wainwright 4th Annual Ophthalmology Virtual Conference, August 15, 2024 (Virtual)H.C. Wainwright 26th Annual Global Investment Conference, September...
Nasdaq GlobeNewswire
19/07/2024

Rona Therapeutics Raises $35 Million Series A+ Financing to Advance Innovative…

Ms. Stella SHI, CEO and Founder of Rona Therapeutics, commented, "We are thrilled to welcome LongRiver Investments and our other new investors as we progress more best-in-class and first-in-class siRNA programs into global development and catalyzing potential business development opportunities. Rona Therapeutics remains committed to pushing boundaries of RNA medicine in metabolic, obesity, renal and neuro degenerative diseases with Rona's proprietary RNA platform." Ms. Stella SHI, CEO…
PR Newswire
19/07/2024

Casino Group Communication

Casino Group Communication Paris, 18 July 2024Casino Group confirms that Casino Guichard Perrachon has been the subject of a preliminary investigation by the National Financial Prosecutor's Office (PNF: Parquet National Financier) into facts likely to be qualified as price manipulation and private corruption dating back to 2018 and 2019, at the end of which an exchange phase with the PNF has been initiated. At this stage of the proceedings, Casino has not been referred to a criminal court...
Nasdaq GlobeNewswire
18/07/2024

Embla Medical hf: The Centers for Medicare & Medicaid Services (CMS) grants…

The finalized policy, which will take effect on 1 September 2024, does not automatically create access for every person currently classified as a K2 amputee. Treating healthcare professionals will have to establish through medical documentation that a bionic knee (MPK or microprocessor-controlled knee) or other K3 knee would improve the patient's functional health outcomes, help them accomplish activities of daily living, and that lower-level knee options have been considered and ruled out. In…
PR Newswire
18/07/2024

dsm-firmenich to sell MEG-3® fish oil business to KD Pharma Group

The transaction includes dsm-firmenich's MEG-3 business for the Food & Beverage, Dietary Supplement and Pharma markets, together with the production facilities in Piura, Peru and Mulgrave, Canada. The MEG-3 business represented approximately €170 million sales in 2023, with approximately 200 employees who will transfer to KD Pharma. The transaction includes dsm-firmenich's MEG-3 business for the Food & Beverage, Dietary Supplement and Pharma markets, together with the production...
PR Newswire
18/07/2024

Oxurion Receives Transparency Notification from Atlas Special Opportunities…

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – July 18, 2024 – 06:00 PM CET - Oxurion NV(Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation 1it has received a transparency notification as follows: Oxurion received a transparency notification on July 17, 2024, from Atlas Special Opportunities, LLC indicating that as of July 17, 2024, it...
Nasdaq GlobeNewswire
18/07/2024

Invitation to Idorsia's Half Year 2024 Financial Reporting webcast and…

Idorsia will publish its Half Year 2024 Financial Reporting on Thursday July 25, 2024, at 07:00 CEST. An investor conference call and webcast will be held to discuss the results on the same day.Date: Thursday, July 25, 2024 Time: 15:00 CEST / 14:00 BST / 09:00 EDT The call will start with presentations by senior management, followed by a Q&A session.To support your preparations, the consensus estimates can be found under:www.idorsia.com/consensus-estimate...
Nasdaq GlobeNewswire
18/07/2024

Cancer Therapeutics Market is Projected to Attain a USD 299.13 Billion Valuation…

Download a detailed overview:https://www.skyquestt.com/sample-request/cancer-therapeutics-market Download a detailed overview: https://www.skyquestt.com/sample-request/cancer-therapeutics-market Cancer Therapeutics Market Overview: Segments covered in Cancer Therapeutics Market are as follows: Request Free Customization of this report: https://www.skyquestt.com/speak-with-analyst/cancer-therapeutics-market Rising Incidence of Lung Cancer Due to High Air Pollution...
PR Newswire
18/07/2024

Biotechnology Market: Surging Investments and Infrastructure Development Propel…

Biotechnology and related products are required to meet established regulatory guidelines and standards. The major federal agencies in the US responsible for administering the required standards are the Animal and Plant Health Inspection Service (APHIS), US. The Coordinated Framework for the Regulation of Biotechnology outlines a government framework for evaluating products developed using modern biotechnology. This provision is based on existing laws developed to protect public health and the…
PR Newswire
18/07/2024

Biologics Market: Surging with 10.40% CAGR Amid Fewer Chronic Cases | SkyQuest…

The global biologics market plays an important role in the development of new therapies for various diseases. It aims to improve patient outcomes and improve quality of life. While there are driving forces such as the increasing incidence of chronic diseases and advances in biotechnology, there are also inhibiting factors such as high costs and product development though. The global biologics market plays an important role in the development of new therapies for various diseases. It aims to...
PR Newswire
18/07/2024

Global Health Information Exchange Market: USD 2.8B Projection, USD 1.7B Base…

Browse in-depth TOC on "Health Information Exchange Market" Browse in-depth TOC on "Health Information Exchange Market" 526 - Tables 53 - Figures 435 - Pages The updated version of the Health Information Exchange Market report provides comprehensive insights from historical data covering 2022 and 2023 to forecasts up to 2029, with a focus on the CAGR from 2024 to 2029. Key updates include: Market Overview:Features include patent analysis, key conferences & events,...
PR Newswire
18/07/2024
Altri  Comunicati